DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: paliperidone palmitate

Summary for Generic Name: paliperidone palmitate

Tradenames:1
Patents:3
Applicants:1
NDAs:1
Drug Master File Entries: see list27
Suppliers: see list1

Pharmacology for Ingredient: paliperidone palmitate

Clinical Trials for: paliperidone palmitate

A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia
Status: Completed Condition: Schizophrenia

Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia
Status: Recruiting Condition: Schizophrenia (Recent-onset)

Paliperidone Palmitate Efficacy and Safety in Bipolar Disorder Complicated by Alcoholism
Status: Withdrawn Condition: Bipolar Disorder

A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate
Status: Completed Condition: Schizophrenia

A Study of Paliperidone Palmitate in Japanese Patients With Schizophrenia
Status: Completed Condition: Schizophrenia

A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With Schizophrenia
Status: Completed Condition: Schizophrenia

A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia
Status: Completed Condition: Schizophrenia

The Effect of Paliperidone Palmitate in Schizophrenia
Status: Recruiting Condition: Schizophrenia

Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)
Status: Completed Condition: Schizophrenia

A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia
Status: Completed Condition: Schizophrenia

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Janssen Pharms
INVEGA SUSTENNA
paliperidone palmitate
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR022264Jul 31, 2009RXNo<disabled>LABELING CHANGES REGARDING MISSED DOSES
Janssen Pharms
INVEGA SUSTENNA
paliperidone palmitate
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR022264Jul 31, 2009RXNo6,555,544*PED<disabled>Y
Janssen Pharms
INVEGA SUSTENNA
paliperidone palmitate
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR022264Jul 31, 2009RXNo6,077,843*PED<disabled>Y
Janssen Pharms
INVEGA SUSTENNA
paliperidone palmitate
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR022264Jul 31, 2009RXNo5,254,556*PED<disabled>Y
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc